Hedge Fund Manager Again Targets Biogen's MS Drug Patent
An organization with close ties to hedge fund manager Kyle Bass filed a petition with the Patent Trial and Appeal Board on Monday seeking an inter partes review of Biogen MA...To view the full article, register now.
Already a subscriber? Click here to view full article